###begin article-title 0
###xml 28 33 <span type="species:ncbi:9606">Human</span>
Two Factor Reprogramming of Human Neural Stem Cells into Pluripotency
###end article-title 0
###begin p 1
Conceived and designed the experiments: MH PHS BKK. Performed the experiments: MH SS CM AE. Analyzed the data: MH SS CM AE PHS BKK. Contributed reagents/materials/analysis tools: MH SS CM AE PHS. Wrote the paper: MH PHS BKK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 130 135 <span type="species:ncbi:9606">human</span>
###xml 188 195 <span type="species:ncbi:9606">patient</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
Reprogramming human somatic cells to pluripotency represents a valuable resource for the development of in vitro based models for human disease and holds tremendous potential for deriving patient-specific pluripotent stem cells. Recently, mouse neural stem cells (NSCs) have been shown capable of reprogramming into a pluripotent state by forced expression of Oct3/4 and Klf4; however it has been unknown whether this same strategy could apply to human NSCs, which would result in more relevant pluripotent stem cells for modeling human disease.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 303 310 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 197 202 <span type="species:ncbi:9606">human</span>
Here, we show that OCT3/4 and KLF4 are indeed sufficient to induce pluripotency from human NSCs within a two week time frame and are molecularly indistinguishable from human ES cells. Furthermore, human NSC-derived pluripotent stem cells can differentiate into all three germ lineages both in vitro and in vivo.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
We propose that human NSCs represent an attractive source of cells for producing human iPS cells since they only require two factors, obviating the need for c-MYC, for induction into pluripotency. Thus, in vitro human disease models could be generated from iPS cells derived from human NSCs.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 277 280 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Takahashi1">[1]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Park1">[10]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Takahashi1">[1]</xref>
###xml 426 429 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Wernig1">[3]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Meissner1">[5]</xref>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Lewitzky1">[11]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Takahashi2">[12]</xref>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Aoi1">[8]</xref>
###xml 506 510 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Stadtfeld1">[13]</xref>
###xml 548 552 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim1">[14]</xref>
###xml 553 557 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Eminli1">[16]</xref>
###xml 648 652 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim1">[14]</xref>
###xml 653 657 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Eminli1">[16]</xref>
###xml 970 974 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim1">[14]</xref>
###xml 1111 1115 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim2">[15]</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 378 383 <span type="species:ncbi:10090">mouse</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 463 469 <span type="species:ncbi:10090">murine</span>
###xml 516 522 <span type="species:ncbi:10090">murine</span>
###xml 600 606 <span type="species:ncbi:10090">murine</span>
###xml 818 824 <span type="species:ncbi:10090">murine</span>
###xml 894 900 <span type="species:ncbi:10090">murine</span>
###xml 1061 1067 <span type="species:ncbi:10090">murine</span>
###xml 1123 1129 <span type="species:ncbi:10090">murine</span>
Numerous laboratories have demonstrated that human and mouse somatic cells can be reprogrammed into pluripotent stem cells or iPS cells by the forced expression of a characterized set of transcription factors (Oct4, Sox2, c-Myc, Klf4, Nanog, and Lin28) in various combinations [1]-[10]. Oct4, Sox2, c-Myc, and Klf4 were the four original factors that were capable of converting mouse and human fibroblasts into iPs cells [1], [3], [5], [11], [12]. More recently, murine liver, stomach [8], lymphocyte, beta[13], and murine neural stem cells (NSCs) [14]-[16] were also capable of iPs induction. Since murine NSCs already express high levels of Sox2 [14]-[16], it was tested whether these cells could be reprogrammed into iPS cells by only a few critical factors. Indeed, it was shown that Oct4 and Klf4 could reprogram murine NSCs at an efficiency of 0.11%, similar to the reprogramming rate of murine fibroblasts with the original four factors with antibiotic selection [14]. More recently, the forced expression of Oct4 alone was shown sufficient to reprogram murine NSCs, albeit at a low efficiency of 0.014% [15]. Since murine NSCs have been "primed" with several of the factors originally discovered to reprogram fibroblasts into iPS cells, they represent an attractive source of starting material for iPS cell induction studies.
###end p 9
###begin p 10
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Palmer1">[17]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Schwartz1">[18]</xref>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:9606">human</span>
###xml 229 234 <span type="species:ncbi:9606">Human</span>
###xml 418 424 <span type="species:ncbi:10090">murine</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 582 587 <span type="species:ncbi:9606">human</span>
###xml 744 749 <span type="species:ncbi:9606">human</span>
Here we tested whether human NSCs could be reprogrammed into iPS cells utilizing a similar strategy as described above since they represent a more clinically relevant source of cells for basic studies and modeling human disease. Human NSCs can be isolated and cultured from fetal, adult, as well as post-mortem brain tissues, and can differentiate into astrocytes, oligodendrocytes, and neurons [17], [18]. Similar to murine NSCs, human NSCs also express high levels of SOX2 and may therefore only require a limited set of factors for induction into pluripotency. Here we show that human NSCs indeed can be reprogrammed into iPS cells by ectopic expression of OCT3/4 and KLF4. Furthermore, we have demonstrated by several rigorous methods that human NSC-derived iPS cells are molecularly identical to hESCs.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Cell culture and differentiation
###end title 12
###begin p 13
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 127 132 <span type="species:ncbi:9606">Human</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
###xml 921 927 <span type="species:ncbi:9913">bovine</span>
Fetal human NSCs, isolated from the frontal brain cortex of a 28 week term fetus, (SCP-27, P1) were obtained from the National Human Neural Stem Cell Resource (NHNSCR, Orange, CA). Proliferating cells were cultured in DMEM/F12 supplemented with 1% N2 (Invitrogen, Carlsbad CA), 10% BIT-9500 (Stem Cell), 1% penicillin, streptomycin, amphocterin cocktail, EGF (20 ng/ml, Peprotech), and FGF-2 (20 ng/ml, Peprotech). Cells were grown on polyornithine and laminin coated dishes and passaged 1:2 with PBS++ (PBS with 1% BSA). All experiments performed with human NSCs were from passage 10-12. To differentiate NSCs into neurons, proliferating media was replaced with a similar media as described above without growth factors and supplemented with all-trans Retinoic acid (Sigma) at 2 uM and forskolin (Sigma) at 5 uM. To induce astrocytic differentiation, NSCs were cultured in DMEM/F12 supplemented with 1% N2 and 10% fetal bovine serum. Oligodendrocyte differentiation was induced by culturing the cells in DMEM/F12, 1% N2, and IGF-1 (200 ng/ml). In all conditions, cells were allowed to differentiate for 1 week.
###end p 13
###begin p 14
###xml 16 21 <span type="species:ncbi:9606">human</span>
The UC06 (HSF6) human ES cell line (P62) was obtained from the National Stem Cell Bank (NSCB), and the adipose derived mesenchymal stem cell (AD-MSC) line was generously obtained from Dr. Jeffrey Gimble from the Penington Biomedical Research Institute.
###end p 14
###begin p 15
###xml 125 131 <span type="species:ncbi:9913">bovine</span>
To induce mesoderm and endoderm lineages from iPS cells, cells were grown as embryoid bodies (EB) in DMEM/F12 with 10% fetal bovine serum for 2 weeks. EBs were then plated to 12 well culture dishes to allow them to adhere to form a monolayer. To induce ectoderm formation, EBs were cultured in DMEM/F12 and 1% N2 supplemented with retinoic acid (2 uM) and forskolin (5 uM).
###end p 15
###begin title 16
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 46 51 <span type="species:ncbi:9606">human</span>
Viral production and human iPS induction from human NSCs
###end title 16
###begin p 17
###xml 240 241 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 529 530 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 590 591 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 146 149 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
Retroviral vectors containing cDNAs for OCT3/4 and KLF4 were obtained from Addgene (Cambridge, MA) and transfected, along with packaging plasmids CMV Gal-Pol and VSVG, into human embryonic kidney carcinoma 293 cells (HEK-293) using the CaCl2 transient transfection method. Supernatants were collected for 3 consecutive days beginning 48 hours after transfection. Virus was concentrated by centrifugation at 90,000x g for 2 hours at 4degreesC, and resuspended in 200 microl PBS. Viral titers were determined to be approximately 108 viral particles/ml based on immunocytochemical analysis. 106 human NSCs (passage 10) were infected with retroviruses encoding OCT3/4 alone or OCT3/4 and KLF4 at an MOI of 10 in human NSC media. In two-factor reprogramming experiments, 80% of cells were infected with both OCT3/4 and KLF4. Similar targeting efficiencies were obtained when OCT3/4 was transduced alone.
###end p 17
###begin title 18
Bisulfite sequencing
###end title 18
###begin p 19
###xml 22 27 <span type="species:ncbi:9606">human</span>
DNA was isolated from human NSCs, ESCs and iPS cells and treated with bisulfite using the EpiTect Bisulfite Kit (Qiagen) according to manufacturer's instructions. Amplified products were purified using gel filtration columns (Qiagen), cloned into the pCR2.1-TOPO vector (Invitrogen), and sequenced with M13 forward and reverse primers.
###end p 19
###begin title 20
Alkaline phosphatase staining
###end title 20
###begin p 21
Alkaline phosphatase staining was performed with the Alkaline Phosphatase Detection Kit (Millipore) according to manufacturer's instructions.
###end p 21
###begin title 22
qPCR and RT-PCR analysis
###end title 22
###begin p 23
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 223 231 223 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007044.s002">Table S1</xref>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 392 397 <span type="species:ncbi:9606">Human</span>
RNA was harvested from proliferating HSF6 hESCs (P67) and MSCs (P10). Total RNA was reverse transcribed with RT2 First Strand Kit (SABiosciences) according to the manufacturer's instructions. Primer sequences are listed in Table S1. Real-time quantitative PCR reactions were performed using RT2 Real-Time SYBR Green/Rox PCR Master Mix (SABiosciences) and run on an RT2 Profiler PCR Array for Human Embryonic Stem Cells (SABiosciences).
###end p 23
###begin title 24
Immunofluorescent analysis
###end title 24
###begin p 25
###xml 277 285 271 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007044.s002">Table S1</xref>
###xml 103 109 <span type="species:ncbi:9793">donkey</span>
Cells were fixed with 4% PFA, followed by three rinses of TBS for 5 minutes, and then blocked with 10% donkey serum with 0.1% Triton X-100. All primary antibodies were diluted in blocking solution and incubated overnight at 4degreesC. Primary antibodies utilized are listed in Table S1. Nuclei were counterstained with DAPI. All images were captured using a Zeiss LSM510-META confocal laser-scanning microscope (Zeiss, Thornwood, NY).
###end p 25
###begin title 26
Teratoma analysis
###end title 26
###begin p 27
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 147 156 <span type="species:ncbi:10090">nude mice</span>
Teratomas were generated from iPS clones 1 and 3 by subcutaneous injection of 1x106 cells into the dorsal flank of isoflurane-anesthetized athymic nude mice (Jackson Labs). Teratomas were recovered 3-4 weeks post-injection, fixed for 24 hours in 10% formalin, embedded in paraffin, and sectioned at a thickness of 10 microM. Sections were stained for hematoxylin and eosin.
###end p 27
###begin title 28
Karyotype analysis
###end title 28
###begin p 29
###xml 15 20 <span type="species:ncbi:9606">human</span>
Karyotyping of human NSC-derived iPS lines was performed at the Molecular Cytogenetics shared resource at the Ohio State University Comprehensive Cancer Center. Karyotyping was performed on iPS lines 1 and 2.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NSCs Express Genes Associated With Pluripotency
###end title 31
###begin p 32
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Darr1">[19]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Boyer1">[20]</xref>
ESCs are maintained in a state of pluripotency by a precise regulation of numerous intrinsic and extrinsic factors. In hESCs, Fibroblast growth factor (FGF), activin, and Bone morphogenetic signaling (BMP) signaling have been shown to be critical in maintaining self-renewal [19]. In addition, intrinsic factors such as OCT3/4, SOX2, and NANOG are generally regarded as the central core of genes that keep hESCs in an undifferentiated state capable of indefinite self-renewal [20].
###end p 32
###begin p 33
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Darr1">[19]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Cai1">[21]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Tsai1">[23]</xref>
###xml 517 528 517 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g001">Figure 1B&#8211;D</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Palmer1">[17]</xref>
###xml 857 866 857 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g001">Figure 1E</xref>
###xml 1581 1585 1581 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim1">[14]</xref>
###xml 306 311 <span type="species:ncbi:9606">Human</span>
###xml 1393 1398 <span type="species:ncbi:10090">mouse</span>
###xml 1553 1558 <span type="species:ncbi:10090">mouse</span>
In contrast, hNSCs differ greatly from hESCs in their growth properties, differentiation potential, and gene expression profile. As shown in 1A, similar to hESCs, hNSCs express high levels of SOX2, which is considered a key regulator of pluripotency [19], and NESTIN, a protein specific to NSCs [21]-[23]. Human NSCs have been generally considered to have limited differentiation with the capacity to differentiate into only neurons, astrocytes, and oligodendrocytes under permissive conditions, as we have observed (Figure 1B-D). In addition, the self-renewal capacity of hNSCs is more limited than hESCs [17]. To further investigate additional similarities between hNSCs and hESCs at the transcriptional level, we analyzed the expression of key genes involved in hESC self-renewal and pluripotency utilizing semi-quantitative RT-PCR analysis. As shown in Figure 1E, all key genes involved in maintaining pluripotency were expressed in hESCs, as expected. In contrast, hNSCs were shown to express a more limited subset of factors, which included SOX2, c-MYC, and KLF4. To quantitatively determine differences between the expression levels of these genes in hNSCs and hESCs, we utilized real time RT-PCR. Our results showed that hNSCs express 1.4 fold higher levels of SOX2, fourfold lower levels of c-MYC, and threefold lower levels of KLF4 relative to hESC expression levels. In comparison, mouse NSCs were reported to express twofold higher levels of Sox2, an eightfold lower level of Klf4, and a tenfold higher level of c-Myc expression relative to mouse ESC expression levels [14].
###end p 33
###begin title 34
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NSCs express several genes involved in the maintenance of pluripotency.
###end title 34
###begin p 35
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 331 336 <span type="species:ncbi:9606">human</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 443 448 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
Human NSCs express SOX2 and NESTIN (A) and are tri-potent, which can differentiate into astrocytes shown by GFAP (green) and S100-Beta (red) staining (B), neurons shown by TUJ1 staining (green) (C), and oligodendrocytes shown by O4 staining (green) (D). (E) Semi-quantitative RT-PCR analysis of key pluripotency genes expressed in human ES cells and several lacking in human NSCs. (F) Quantitative RT-PCR analysis of key pluripotency genes in human NSCs relative to hESCs. (G) Heat map derived from quantitative RT-PCR depicting relative expression of multiple genes associated with pluripotency comparing human MSCs, NSCs, and ESCs.
###end p 35
###begin p 36
###xml 598 607 598 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g001">Figure 1G</xref>
###xml 917 925 917 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 998 1002 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Daheron1">[24]</xref>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Wright1">[26]</xref>
###xml 453 458 <span type="species:ncbi:9606">human</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
We further extended our analysis of pluripotency gene expression to a much larger scale to potentially identify similar signaling cascades that might be conserved between hNSCs and hESCs. We utilized quantitative RT-PCR to measure 46 genes that are expressed in hESCs, which function as cytokines, growth factors, and other signaling molecules. In addition to analyzing pluripotency gene expression in hESCs and hNSCs, we also performed our analysis on human mesenchymal stem cells (hMSCs), which are also considered to have a limited differentiation potential. As depicted in a heat map format in Figure 1G, most of the genes analyzed are expressed at higher levels in hESCs compared to hNSCs or hMSCs, as expected. Interestingly, hNSCs highly expressed receptors involved in STAT signal transduction such as LIFR and IL6ST. Indeed, it has been demonstrated that LIF promotes self-renewal of human neural stem cells in vitro, though STAT signaling is insufficient to promote self-renewal in hESCs [24]-[26]. In sum, analysis of genes involved in pluripotency in hNSCs has revealed these cells are primed with several factors such as SOX2, c-MYC, and KLF4, which might support more readily their induction into a pluripotent state.
###end p 36
###begin title 37
###xml 32 37 <span type="species:ncbi:9606">Human</span>
iPS Cells Can Be Generated from Human NSCs by Exogenous Expression of OCT3/4 and KLF4
###end title 37
###begin p 38
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1048 1052 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Jiang1">[27]</xref>
###xml 1054 1058 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Nandan1">[28]</xref>
###xml 1150 1154 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim1">[14]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Eminli1">[16]</xref>
###xml 1463 1472 1463 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g002">Figure 2A</xref>
###xml 1626 1638 1626 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g002">Figure 2B, C</xref>
###xml 1820 1821 1820 1821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 2051 2055 2051 2055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Kim1">[14]</xref>
###xml 2233 2236 2233 2236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Nakagawa1">[6]</xref>
###xml 2238 2241 2238 2241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Yu1">[9]</xref>
###xml 2243 2247 2243 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Park1">[10]</xref>
###xml 2249 2253 2249 2253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Takahashi2">[12]</xref>
###xml 2657 2667 2657 2667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007044.s001">Figure S1A</xref>
###xml 2795 2804 2795 2804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g002">Figure 2D</xref>
###xml 2970 2981 2970 2981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g002">Figure 2E&#8211;M</xref>
###xml 3092 3101 3092 3101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g002">Figure 2N</xref>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
###xml 689 694 <span type="species:ncbi:9606">human</span>
###xml 1139 1144 <span type="species:ncbi:10090">mouse</span>
###xml 1925 1930 <span type="species:ncbi:10090">mouse</span>
###xml 2017 2022 <span type="species:ncbi:9606">human</span>
###xml 2040 2045 <span type="species:ncbi:10090">mouse</span>
###xml 2091 2096 <span type="species:ncbi:9606">human</span>
###xml 2314 2319 <span type="species:ncbi:9606">human</span>
###xml 3076 3081 <span type="species:ncbi:10090">mouse</span>
Since we observed robust expression of SOX2 and modest expression of c-MYC and KLF4 in our human NSC cultures, we tested if ectopic expression of OCT3/4 per se would be sufficient to convert them from multipotent to pluripotent stem cells. Furthermore, it was recently demonstrated that Oct3/4 expression in mouse NSCs was sufficient to convert them into iPS cells, suggesting this strategy might function in hNSCs. We infected 1x106 hNSCs with OCT3/4 retrovirus, and after multiple attempts and long incubation periods greater than two months, we did not observe any colonies. This inability to reprogram human NSCs with OCT3/4 alone might indicate possible differences between mouse and human NSCs. To rule out whether this might be due to low targeting efficiencies, we performed immunocytochemistry against OCT3/4 and observed an 80% infection rate (data not shown), suggesting this was not an inability to deliver OCT3/4 to hNSCs. Since KLF4 has been shown to play a critical role in chromatin remodeling and maintaining self-renewal in hESCs [27], [28], and it was shown to support iPS cell induction in conjunction with Oct3/4 from mouse NSCs [14], [16], we introduced it into our iPS induction strategy. We achieved a targeting efficiency of approximately 80% with both retroviruses containing OCT3/4 and KLF4. The day after retroviral transduction, cells were grown in NSC media for four days following a change to hESC media to support iPS cell growth (Figure 2A). Within ten days we observed localized areas of dense cell growth and within three weeks, we observed cells that were morphologically similar to hESCs (Figure 2B, C). Based on the percentage of cells that were infected with both OCT3/4 and KLF4 at 80%, we calculated our reprogramming efficiency to be approximately 0.01% (80 colonies from 0.8x106 cells infected with both OCT3/4 and KLF4), which was elevenfold less efficient than iPS induction from mouse NSCs with Oct3/4 and Klf4. This may be due to lower endogenous expression of c-MYC in human NSCs compared to mouse NSCs [14]. The efficiencies of reprogramming human dermal and neonatal foreskin fibroblasts to iPS cells utilizing OCT4, SOX2, KLF4, and c-MYC have been shown to range between 0.01-0.02% [6], [9], [10], [12] which is quite similar to our reprogramming efficiencies on human NSCs with OCT3/4 and KLF4. We picked seven iPS clones that were morphologically similar to hES cells, and of those three iPS lines were generated. To verify whether the retroviral KLF4 and OCT3/4 transgenes were present in our iPS clones, we performed PCR analysis and observed both transgenes were integrated in all clones we analyzed (Figure S1A). In addition, iPS cells stained positive for alkaline phosphatase (AP) activity, which is a prototypical marker for ES cells (Figure 2D). We also found expression of a wide panel of markers expressed in hESCs in our iPS cells, which include OCT3/4, SSEA-3, TRA-1-60, TRA-1-81, NANOG, KLF4, and LIN28 (Figure 2E-M). In contrast, SSEA-1 staining was not observed, as expected, since it is marker exclusive to mouse ES cells (Figure 2N). All iPS lines (iPS1-iPS3) showed the full complement of pluripotency markers utilized.
###end p 38
###begin title 39
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Human iPS cells can be generated from human NSCs.
###end title 39
###begin p 40
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 323 328 <span type="species:ncbi:9606">human</span>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
(A) Schematic depicting the strategy to induce pluripotency in human NSCs. (B) After 21 days iPSC colonies emerge, which are molecularly indistinguishable from hESC colonies under low and high magnification (C) and stain positive for alkaline phosphatase (D). (E-M) Extensive immunocytochemical analysis of genes expressed human NSC-derived iPS cells, which are also expressed in hESCs except for SSEA-1 (N), which is only expressed in mouse ES cells.
###end p 40
###begin p 41
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Hotta1">[29]</xref>
###xml 421 430 421 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g003">Figure 3A</xref>
###xml 616 625 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g003">Figure 3A</xref>
To further confirm the authenticity of our iPS clones, we performed quantitative RT-PCR on four major pluripotency inducing genes, OCT3/4, KLF4, SOX2, and c-MYC, in three of our iPS clones. We also performed qRT-PCR to determine whether the retroviral OCT3/4 and KLF4 transgenes were silenced, which has been shown to be a reliable measure for efficient reprogramming of somatic cells into pluripotency [29]. As shown in Figure 3A, all iPS lines tested showed similar levels of these factors compared to hESC cells. In addition, all lines showed nearly complete silencing of the transgenes for both OCT3/4 and KLF4 (Figure 3A).
###end p 41
###begin title 42
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NSC-derived iPS cells are genetically similar to hESCs.
###end title 42
###begin p 43
###xml 214 219 <span type="species:ncbi:9606">human</span>
(A) Quantitiative RT-PCR analysis of key pluripotency inducing genes from endogenous (shown as "E") loci or transgenic (shown as "T") loci normalized to hESC gene expression. (B) Bisulfite sequence analysis of the human OCT3 and NANOG promoters in hESCs and multiple iPS clones. Unfilled or filled circles represent unmethylated or methylated CpGs, respectively. (C) Karyotype analysis of multiple iPS clones.
###end p 43
###begin p 44
###xml 503 512 503 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g003">Figure 3B</xref>
###xml 954 964 954 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007044.s001">Figure S1b</xref>
###xml 1176 1185 1176 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g003">Figure 3C</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
A more stringent test was utilized to determine whether reprogramming human NSCs was accompanied by demethylation of the OCT3/4 and NANOG promoters, both of which must be active to maintain pluripotency. To do this, we performed bisulfite sequencing to evaluate the methylation status of these promoters in several of our iPS lines. Consistent with our earlier findings analyzing OCT3/4 and NANOG gene expression, both promoters were hypermethylated and hypomethylated in hNSCs and hESCs, respectively (Figure 3B). All of these data highly support that iPS cells derived from hNSCs can be reprogrammed to a hESC-like state at the molecular level. This reprogramming to an ESC like state was also accompanied by an increase in proliferation as shown by flow cytometry analysis (FACS). Quantification of this data showed that hNSC-derived iPS cells were more similar to hESCs in the percentage of cells in the G2/M phase of the cell cycle than were hNSCs (Figure S1b). This increase in proliferation was not due to transformation in culture since karyotypic analysis of all iPS lines analyzed (iPS1-2) revealed a normal number of chromosomes (46XX) without gross abnormalities (Figure 3C).
###end p 44
###begin title 45
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NSC-derived iPS Cells Can Differentiate into All Three Germ Lineages In vitro and In vivo
###end title 45
###begin p 46
###xml 315 324 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g004">Figure 4A</xref>
###xml 652 660 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g004">Figure 4</xref>
###xml 759 768 759 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g004">Figure 4B</xref>
###xml 822 834 822 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g004">Figure 4D, E</xref>
###xml 898 910 898 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g004">Figure 4G, H</xref>
###xml 930 937 930 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1299 1314 1299 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007044-g004">Figure 4C, F, I</xref>
###xml 1543 1551 1543 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1556 1563 1556 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 1027 1036 <span type="species:ncbi:10090">nude mice</span>
Pluripotent stem cells are capable of differentiating into all three germ lineages of the human body, and we thus investigated the developmental potential of our i-PS cells to determine whether they could differentiate into ectoderm, endoderm, and mesoderm. We differentiated our iPS cells as embryoid bodies (EB) (Figure 4A) in the presence of FBS to induce endodermal and mesodermal fates, and in the presence of retinoic acid to induce an ectodermal fate, and after ten days allowed them to adhere to tissue culture dishes. After the EBs adhered, we analyzed our cultures for different germ layer markers by immunocytochemical analysis. As shown in Figure 4, all three germ layers developed in our cultures as shown by alphafetoprotein (AFP) for endoderm (Figure 4B), smooth muscle actin (SMA) and desmin for mesoderm (Figure 4D, E), glial fibrillary acid protein (GFAP) and SMI31 for ectoderm (Figure 4G, H). To determine the in vivo developmental potential of our iPS lines, we injected iPS-1 and iPS-3 lines into athymic nude mice to induce teratomas. The teratomas analyzed were shown to contain muscle tissues, which are derivatives of mesoderm, primitive duct formations (indicated by arrows), which are derivatives of endoderm, and epidermal structures, which are derivatives of ectoderm (Figure 4C, F, I). All iPS lines tested (iPS1, 3) gave rise to teratomas with all three germ layers. These data support the developmental potential of the iPS cells showing that they have the ability to give rise to all three cell lineages both in vitro and in vivo, which are critical attributes of pluripotent stem cells.
###end p 46
###begin title 47
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NSC-derived iPS cells can form all three germ lineages both in vitro and in vivo.
###end title 47
###begin p 48
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 338 345 338 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 272 281 <span type="species:ncbi:10090">nude mice</span>
(A) iPS cells can form embryoid bodies (EB) and can differentiate in vitro to endoderm shown by alpha fetoprotein (AFP) (B), mesoderm shown by smooth muscle actin (SMA) and desmin (D,E), and ectoderm shown by GFAP and SMI31 staining (G,H). iPS cells injected into athymic nude mice form teratomas and differentiate into all germ lineages in vivo (C,F,I).
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Watanabe1">[30]</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Li1">[31]</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 295 300 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 555 560 <span type="species:ncbi:10090">mouse</span>
###xml 565 570 <span type="species:ncbi:9606">human</span>
###xml 818 823 <span type="species:ncbi:9606">human</span>
###xml 895 900 <span type="species:ncbi:9606">human</span>
Here we have identified another source of human cells that can be efficiently reprogrammed into human iPS cells by the ectopic exposure of only two factors, namely OCT3/4 and KLF4. The mechanism of this two-factor reprogramming is probably largely due to the intrinsic expression of SOX2 within human NSCs, which has been shown to a major protein involved in maintaining pluripotency in hESCs. It is interesting that OCT3/4 was not sufficient to convert human NSCs into iPS cells utilizing our techniques. This could reflect intrinsic differences between mouse and human NSCs, but might still be attainable by altering some experimental parameters such as infecting more target cells, extending culturing conditions, and incubating target cells with a rho-kinase inhibitor small molecule, shown to enhance survival of human ES cells [30], [31]. Through extensive examination, we have shown that human NSC-derived iPS cells are phenotypically identical to hESCs by all pluripotential markers analyzed and for their ability to differentiate into all three major germ lineages.
###end p 50
###begin p 51
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Lyssiotis1">[32]</xref>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 643 648 <span type="species:ncbi:10090">mouse</span>
###xml 735 740 <span type="species:ncbi:9606">human</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
The utilization of human NSCs as a potential source for reprogramming into iPS cells offers multiple advantages. Since the reprogramming process requires only two factors, the chance of insertional mutagenesis is minimized. Furthermore, obviating the requirement for c-MYC reduces the risk of inducing cancerous cells. In addition, since two factors are sufficient for human iPS induction from NSCs, it may be possible to substitute one or both of these factors with small molecules that activate OCT3/4 or KLF4 gene expression. Indeed, a recent report has demonstrated that the small molecule, kenpaullone could replace KLF4 in reprogramming mouse fibroblasts into iPS cells [32]. This report suggests it may be possible to reprogram human NSCs into iPS cells by OCT3/4 and kenpaullone, further minimizing the undesired effects of utilizing retroviral vectors. Another advantage of utilizing human NSCs is that they endogenously express SOX2, KLF4, and c-MYC, which provides a basis to analyze the mechanism of iPS induction with two factors.
###end p 51
###begin p 52
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Banito1">[33]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007044-Utikal1">[38]</xref>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 615 620 <span type="species:ncbi:9606">human</span>
###xml 696 703 <span type="species:ncbi:9606">patient</span>
###xml 749 754 <span type="species:ncbi:9606">human</span>
Research on induced pluripotency has been rapidly expanding providing more efficient means to generate iPS cells. Indeed, a plethora of research reports has implicated the master guardian of the genome, p53, as being a major hindrance to the iPS induction process [33]-[38]. By impairing the p53 pathway on multiple levels, researchers were able to dramatically enhance the iPS cell induction up to 100 fold. By impairing the p53 pathway in hNSCs, it is probable that this will also increase the rate of IPS cell induction from these cells. In sum, human NSCs represent an invaluable source of cells to investigate human iPS induction, and also represent a potential source of cells for deriving patient-specific pluripotent stem cells for modeling human disease.
###end p 52
###begin title 53
Supporting Information
###end title 53
###begin p 54
###xml 372 392 372 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007044.s002">Supplemental Table 1</xref>
Multiple iPS lines show integration of both the OCT3/4 and KLF4 transgenes and progress through the cell cycle similarly to hESCs. (A) Genotype analysis of multiple iPS lines for OCT3/4 and KLF4 transgenes. (B) FACs analysis of the cell cycle in proliferating hNSCs, hESCs, and iPS cells with a chart showing percentages of cell types in the G2/M phase of the cell cycle. Supplemental Table 1. Information regarding the primary antibodies utilized in immunofluorescence analysis and primers utilized in RT-PCR, genotyping, and bisulfite sequencing analyses.
###end p 54
###begin p 55
(0.95 MB TIF)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007044.s002">Table S1</xref>
Table S1. Information regarding the primary antibodies utilized in immunofluorescence analysis and primers utilized in RT-PCR, genotyping, and bisulfite sequencing analyses.
###end p 57
###begin p 58
(0.05 MB DOC)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
###end article-title 61
###begin article-title 62
Generation of germline-competent induced pluripotent stem cells.
###end article-title 62
###begin article-title 63
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
###end article-title 63
###begin article-title 64
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.
###end article-title 64
###begin article-title 65
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
###end article-title 65
###begin article-title 66
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
###end article-title 66
###begin article-title 67
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
c-Myc is dispensable for direct reprogramming of mouse fibroblasts.
###end article-title 67
###begin article-title 68
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Generation of pluripotent stem cells from adult mouse liver and stomach cells.
###end article-title 68
###begin article-title 69
###xml 49 54 <span type="species:ncbi:9606">human</span>
Induced pluripotent stem cell lines derived from human somatic cells.
###end article-title 69
###begin article-title 70
###xml 17 22 <span type="species:ncbi:9606">human</span>
Reprogramming of human somatic cells to pluripotency with defined factors.
###end article-title 70
###begin article-title 71
Reprogramming somatic cells towards pluripotency by defined factors.
###end article-title 71
###begin article-title 72
###xml 47 52 <span type="species:ncbi:9606">human</span>
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
###end article-title 72
###begin article-title 73
Reprogramming of pancreatic beta cells into induced pluripotent stem cells.
###end article-title 73
###begin article-title 74
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
###end article-title 74
###begin article-title 75
Oct4-induced pluripotency in adult neural stem cells.
###end article-title 75
###begin article-title 76
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
###end article-title 76
###begin article-title 77
###xml 36 41 <span type="species:ncbi:9606">human</span>
Cell culture. Progenitor cells from human brain after death.
###end article-title 77
###begin article-title 78
###xml 75 80 <span type="species:ncbi:9606">human</span>
Isolation and characterization of neural progenitor cells from post-mortem human cortex.
###end article-title 78
###begin article-title 79
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human embryonic stem cells: the battle between self-renewal and differentiation.
###end article-title 79
###begin article-title 80
###xml 45 50 <span type="species:ncbi:9606">human</span>
Core transcriptional regulatory circuitry in human embryonic stem cells.
###end article-title 80
###begin article-title 81
Properties of a fetal multipotent neural stem cell (NEP cell).
###end article-title 81
###begin article-title 82
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells.
###end article-title 82
###begin article-title 83
A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.
###end article-title 83
###begin article-title 84
###xml 54 59 <span type="species:ncbi:9606">human</span>
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
###end article-title 84
###begin article-title 85
###xml 31 36 <span type="species:ncbi:9606">human</span>
Maintenance of pluripotency in human embryonic stem cells is STAT3 independent.
###end article-title 85
###begin article-title 86
###xml 19 24 <span type="species:ncbi:9606">human</span>
Gene expression in human neural stem cells: effects of leukemia inhibitory factor.
###end article-title 86
###begin article-title 87
A core Klf circuitry regulates self-renewal of embryonic stem cells.
###end article-title 87
###begin article-title 88
The role of Kruppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells.
###end article-title 88
###begin article-title 89
Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
###end article-title 89
###begin article-title 90
###xml 49 54 <span type="species:ncbi:9606">human</span>
A ROCK inhibitor permits survival of dissociated human embryonic stem cells.
###end article-title 90
###begin article-title 91
###xml 57 62 <span type="species:ncbi:9606">human</span>
The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation.
###end article-title 91
###begin article-title 92
###xml 17 23 <span type="species:ncbi:10090">murine</span>
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.
###end article-title 92
###begin article-title 93
Senescence impairs successful reprogramming to pluripotent stem cells.
###end article-title 93
###begin article-title 94
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.
###end article-title 94
###begin article-title 95
Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
###end article-title 95
###begin article-title 96
The Ink4/Arf locus is a barrier for iPS cell reprogramming.
###end article-title 96
###begin article-title 97
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.
###end article-title 97
###begin article-title 98
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.
###end article-title 98
###begin p 99
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 99
###begin p 100
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NIH/NINDS 1R01NS064492-01A1, Project A.L.S. (), Crail H. Neilsen Foundation (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 100

